November 13, 2019

Please reload

Recent Posts

hemotune is awarded 0.5 million euros by EIT Health

July 9, 2020

Please reload

Featured Posts

hemotune AG receives grant from Innosuisse

February 7, 2020




hemotune AG together with ETH Zurich and Wyss Zurich received an Innosuisse grant worth CHF 580’000, to further advance hemotune’s sepsis treatment. The grant supports the development of hemotune’s magnetic blood purification that selectively removes multiple key drivers of sepsis. Sepsis is a dysregulated immune response to infection with globally 11 million deaths. Its most severe form septic shock has mortality rates of 30-50%.


hemotune’s treatment is designed to restore adequate immune function in septic shock patients and to improve their outcomes. Innosuisse, the Swiss Innovation Agency, supports innovation projects between research institutes and industry that benefit the Swiss economy and society.

We are very happy to receive this support on our journey to fight sepsis.

Share on Facebook
Share on Twitter
Please reload

Follow Us
Please reload

Search By Tags